[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07648953":3,"trial-entities:NCT07648953":88,"trial-summary:NCT07648953":92},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":20,"primary_purpose":21,"phases":22,"enrollment_info":24,"interventions":27,"primary_outcomes":34,"secondary_outcomes":39,"sex":49,"minimum_age":50,"maximum_age":51,"healthy_volunteers":14,"eligibility_criteria":52,"std_ages":62,"locations":64,"central_contacts":81,"overall_officials":83,"references":86,"see_also_links":87},"NCT07648953","198894","Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors","RECRUITING","2027-05","2026-05","2026-06-15","2026-07","University of Utah","OTHER",false,"This exploratory mixed-methods study aims to examine receipt of treatment and decision-making among rural cancer patients in Utah. Guided by Conceptual Model of Healthcare Access, the study will integrate, survey and cancer registry data with patient interviews to better understand how travel burden, socioeconomic conditions, health literacy, and other contextual factors shape treatment location and access to care . While the setting of this research is specific to Utah, a state with vast rural regions and only one National Cancer Institute (NCI)-designated cancer center, the findings may inform policy and practice improvements in other states with similar geographic and healthcare infrastructure. Thus, the study has potential relevance for advancing rural cancer equity nationwide.\n\nUnderstanding how rural cancer patients make treatment decisions is essential to addressing persistent disparities in cancer care access and outcomes. While geographic barriers and structural inequities are well-documented, less is known about the individual and contextual factors that shape patients' choices about where and how to receive treatment. This mixed-methods study will examine receipt of treatment, decision-making, and patient experience among rural cancer patients in Utah, with attention to travel burden, referral pathways, health literacy, and perceived barriers to care.",null,[18],"HPV Vaccination",[],"INTERVENTIONAL","PREVENTION",[23],"NA",{"count":25,"type":26},55,"ESTIMATED",[28],{"type":29,"name":30,"description":31,"armGroupLabels":32},"BEHAVIORAL","Microvideos: HPV Vaccination Education","To educate survivors of childhood cancers about a key cancer prevention strategy, HPV vaccination. The core microvideos will focus on the 5 Ws of HPV vaccination: Who should get vaccinated, What HPV vaccination protects against, When to get vaccinated, Where to access the vaccine, Why it matters-designed particularly for cancer survivors.",[33],"HPV Vaccination Education",[35],{"measure":36,"description":37,"timeFrame":38},"Feasibility of Microvideo education","Feasibility will be defined as ≥80% of participants completing the intervention and study surveys.","up to 4 weeks",[40,43,46],{"measure":41,"description":42,"timeFrame":38},"Acceptability of Microvideo Education","Acceptability will be summarized using means, standard deviations, and proportions of participants indicating strong agreement (scores ≥4 out of 5) with positive statements about the microvideos and platform.\n\nScores range from 0-5, with higher scores indicating more positivity about the microvideos and platform, and lower scores indicating less positivity about the microvideos and platform.",{"measure":44,"description":45,"timeFrame":38},"Satisfaction Acceptability of Microvideo Education","Satisfaction will be summarized using means, standard deviations, and proportions of participants indicating strong agreement (scores ≥4 out of 5) with positive statements about the microvideos and platform.\n\nScores range from 0-5, with higher scores indicating more positivity about the microvideos and platform, and lower scores indicating less positivity about the microvideos and platform.",{"measure":47,"description":48,"timeFrame":38},"HPV Vaccine Intention","To assess HPV vaccine intention among unvaccinated emerging adult survivors of childhood cancer through a pilot quasi-experimental social media intervention.\n\nThis outcome measure will report the count of participants who intended to receive the HPV Vaccine after the microvideo education.","ALL","18 Years","26 Years",{"inclusion":53,"exclusion":57,"raw_text":61},[54,55,56],"Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.","Currently use Facebook or willing to create a Facebook account to use for the duration of the study.","At the time of enrollment, have not completed all recommended doses of the HPV vaccine.",[58,59,60],"Unable to speak and understand English.","Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.","Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.","Inclusion Criteria:\n\n* Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.\n* Currently use Facebook or willing to create a Facebook account to use for the duration of the study.\n* At the time of enrollment, have not completed all recommended doses of the HPV vaccine.\n\nExclusion Criteria:\n\n* Unable to speak and understand English.\n* Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.\n* Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.",[63],"ADULT",[65],{"facility":12,"status":7,"city":66,"state":67,"zip":68,"country":69,"contacts":70,"geoPoint":78},"Salt Lake City","Utah","84112","United States",[71,76],{"name":72,"role":73,"phone":74,"email":75},"Echo Warner, MPH, PhD, SB","CONTACT","801-244-7040","echo.warner@hci.utah.edu",{"name":72,"role":77},"PRINCIPAL_INVESTIGATOR",{"lat":79,"lon":80},40.76078,-111.89105,[82],{"name":72,"role":73,"phone":74,"email":75},[84],{"name":72,"affiliation":85,"role":77},"Huntsman Cancer Institute",[],[],{"nct_id":4,"conditions":89,"biomarkers":91},[90],"Childhood Malignant Neoplasm",[],{"nct_id":4,"found":14,"summary":16,"prompt_version":16}]